Medicine to prevent low platelets from chemotherapy in breast cancer
Treatments studied
This study tests a medicine called romiplostim N01 to see if it can prevent low platelet counts caused by chemotherapy in breast cancer patients. It may help reduce the risk of bleeding and allow you to complete your chemotherapy on time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer confirmed by biopsy.
- You are between 18 and 75 years old.
- Your platelet count dropped low after your last chemotherapy cycle.
- Your platelet count is above 100 at the start of the study.
- You have not taken this specific medicine before.
- You have had at least one prior cancer treatment like chemo, radiation, or targeted therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if romiplostim, a drug that helps the body make platelets, can speed up platelet recovery after a special type of stem cell transplant from a half-matched donor. It may help reduce bleeding risk during the recovery period.
This trial tests a new form of romiplostim (a drug that boosts platelets) in breast cancer patients whose platelet counts have dropped due to chemotherapy. It aims to see if it can safely raise platelet levels to reduce bleeding risk and allow chemo to continue.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests a drug called romiplostim to help raise platelet levels in children and young adults (ages 6–24) whose platelets drop due to chemotherapy. It’s for those with solid tumors or other non-marrow cancers who are still getting strong treatment.
This trial tests a drug called romiplostim N01 to see if it can increase low platelet counts caused by radiation therapy or radiation combined with other cancer treatments. Platelets help your blood clot, and low levels can be dangerous.
This trial tests a medicine called Romiplostim N01 to help raise platelet levels in people with solid tumors who have low platelets from chemo, radiation, or immunotherapy. The goal is to see if it can safely improve platelet counts so patients can continue their cancer treatment.
Hear when a new Thrombocytopenia Chemotherapy Induced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.